Teva Pharma Financials
| TEVA Stock | USD 19.27 0.18 0.93% |
Please note, the presentation of Teva Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Teva Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Teva Pharma's management manipulating its earnings.
Teva Pharma Stock Summary
Teva Pharma competes with Viatris, Bausch Health, Tilray, Gilead Sciences, and Bristol Myers. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. Teva Pharmaceutical is traded on New York Stock Exchange in the United States.| Foreign Associate | Israel |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | New York Stock Exchange |
| ISIN | US8816242098 |
| CUSIP | 881624209 |
| Location | Israel |
| Business Address | 124 Dvora HaNevia |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.tevapharm.com |
| Phone | 972 3 914 8213 |
| Currency | USD - US Dollar |
Teva Pharma Key Financial Ratios
| Return On Equity | -0.0242 | ||||
| Return On Asset | 0.0537 | ||||
| Target Price | 23.56 | ||||
| Beta | 0.73 |
Teva Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Teva Pharma's current stock value. Our valuation model uses many indicators to compare Teva Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Teva Pharma competition to find correlations between indicators driving Teva Pharma's intrinsic value. More Info.Teva Pharma Industries is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Teva Pharma's earnings, one of the primary drivers of an investment's value.Teva Pharma Industries Systematic Risk
Teva Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Teva Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was nine with a total number of output elements of fifty-two. The Beta measures systematic risk based on how returns on Teva Pharma Industries correlated with the market. If Beta is less than 0 Teva Pharma generally moves in the opposite direction as compared to the market. If Teva Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Teva Pharma Industries is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Teva Pharma is generally in the same direction as the market. If Beta > 1 Teva Pharma moves generally in the same direction as, but more than the movement of the benchmark.
About Teva Pharma Financials
What exactly are Teva Pharma Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Teva Pharma's income statement, its balance sheet, and the statement of cash flows. Potential Teva Pharma investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Teva Pharma investors may use each financial statement separately, they are all related. The changes in Teva Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Teva Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Teva Pharma Thematic Clasifications
Teva Pharma Industries is part of several thematic ideas from Adviser Favorites to Israel Wall Street. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasTeva Pharma September 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Teva Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Teva Pharma Industries. We use our internally-developed statistical techniques to arrive at the intrinsic value of Teva Pharma Industries based on widely used predictive technical indicators. In general, we focus on analyzing Teva Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Teva Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.34 | |||
| Information Ratio | 0.0755 | |||
| Maximum Drawdown | 11.98 | |||
| Value At Risk | (2.31) | |||
| Potential Upside | 2.83 |
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |